Asia · News · The Korea Herald

Korea’s first homegrown GLP-1: Can Hanmi’s Eppe undercut Mounjaro and Wegovy?

Published by The Korea Herald · South Korea 16 h ago

Hanmi Pharmaceutical’s Eppe is poised to challenge Wegovy and Mounjaro in Korea’s fast-growing obesity drug market, with price emerging as a potentially decisiv ...

Read the full article on The Korea Herald Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.koreaherald.com)

Also worth reading

Yonhap

U.S. accuses California woman of spying for China, surveilling Taiwan leader’s son

The Mainichi

Korea’s first homegrown GLP-1: Can Hanmi’s Eppe undercut Mounjaro and Wegovy?

Share

Also worth reading

Delinquent health insurance premiums owed by foreigners total 37.5 bln won

Kai Tak Hospital starts first phase of operations, treats 300 patients on day 1

Honda plans highway test of wireless charging for moving trucks

Ayala Corporation's Notice of Special Stockholders’ Meeting 1/2

U.S. accuses California woman of spying for China, surveilling Taiwan leader’s son

Japan remains 12th in global innovation ranking, trails South Korea, China